Cargando…
Safety evaluation of high-risk myocardial micro-biopsy in a swine model
The objective of the study was to investigate the safety profile of high-risk micro-endomyocardial biopsy (micro-EMB) compared to conventional EMB in a large animal model. Twenty pigs were subjected to a maximum of 30 consecutive biopsies, including sampling from the free ventricular wall, with eith...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917023/ https://www.ncbi.nlm.nih.gov/pubmed/34812914 http://dx.doi.org/10.1007/s00380-021-01995-9 |
_version_ | 1784668451902586880 |
---|---|
author | Chireh, Arvin Sandell, Mikael Grankvist, Rikard Lövljung, Victoria al-Saadi, Jonathan Arnberg, Fabian Lundberg, Johan Settergren, Magnus Holmin, Staffan |
author_facet | Chireh, Arvin Sandell, Mikael Grankvist, Rikard Lövljung, Victoria al-Saadi, Jonathan Arnberg, Fabian Lundberg, Johan Settergren, Magnus Holmin, Staffan |
author_sort | Chireh, Arvin |
collection | PubMed |
description | The objective of the study was to investigate the safety profile of high-risk micro-endomyocardial biopsy (micro-EMB) compared to conventional EMB in a large animal model. Twenty pigs were subjected to a maximum of 30 consecutive biopsies, including sampling from the free ventricular wall, with either micro-EMB (n = 10) or conventional EMB (n = 10). There were no major complications in the micro-EMB group (0/10), compared to six major complications in the EMB group (6/10; p = 0.003). Survival analysis further highlighted these differences (p = 0.004). There were significantly higher volumes of pericardial effusion in the EMB group (p = 0.01). The study shows a safety advantage of micro-EMB compared to standard EMB in the experimental high-risk circumstances investigated in this animal study. These results indicate enhanced possibilities to collect samples from sensitive areas by using the micro-EMB technique instead of standard EMB. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01995-9. |
format | Online Article Text |
id | pubmed-8917023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-89170232022-03-17 Safety evaluation of high-risk myocardial micro-biopsy in a swine model Chireh, Arvin Sandell, Mikael Grankvist, Rikard Lövljung, Victoria al-Saadi, Jonathan Arnberg, Fabian Lundberg, Johan Settergren, Magnus Holmin, Staffan Heart Vessels Original Article The objective of the study was to investigate the safety profile of high-risk micro-endomyocardial biopsy (micro-EMB) compared to conventional EMB in a large animal model. Twenty pigs were subjected to a maximum of 30 consecutive biopsies, including sampling from the free ventricular wall, with either micro-EMB (n = 10) or conventional EMB (n = 10). There were no major complications in the micro-EMB group (0/10), compared to six major complications in the EMB group (6/10; p = 0.003). Survival analysis further highlighted these differences (p = 0.004). There were significantly higher volumes of pericardial effusion in the EMB group (p = 0.01). The study shows a safety advantage of micro-EMB compared to standard EMB in the experimental high-risk circumstances investigated in this animal study. These results indicate enhanced possibilities to collect samples from sensitive areas by using the micro-EMB technique instead of standard EMB. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01995-9. Springer Japan 2021-11-23 2022 /pmc/articles/PMC8917023/ /pubmed/34812914 http://dx.doi.org/10.1007/s00380-021-01995-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Chireh, Arvin Sandell, Mikael Grankvist, Rikard Lövljung, Victoria al-Saadi, Jonathan Arnberg, Fabian Lundberg, Johan Settergren, Magnus Holmin, Staffan Safety evaluation of high-risk myocardial micro-biopsy in a swine model |
title | Safety evaluation of high-risk myocardial micro-biopsy in a swine model |
title_full | Safety evaluation of high-risk myocardial micro-biopsy in a swine model |
title_fullStr | Safety evaluation of high-risk myocardial micro-biopsy in a swine model |
title_full_unstemmed | Safety evaluation of high-risk myocardial micro-biopsy in a swine model |
title_short | Safety evaluation of high-risk myocardial micro-biopsy in a swine model |
title_sort | safety evaluation of high-risk myocardial micro-biopsy in a swine model |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917023/ https://www.ncbi.nlm.nih.gov/pubmed/34812914 http://dx.doi.org/10.1007/s00380-021-01995-9 |
work_keys_str_mv | AT chireharvin safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT sandellmikael safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT grankvistrikard safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT lovljungvictoria safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT alsaadijonathan safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT arnbergfabian safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT lundbergjohan safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT settergrenmagnus safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel AT holminstaffan safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel |